Decrease of cefiderocol <i>in vitro</i> activity against carbapenemases-producing Gram-negative bacteria
Not available.
Saved in:
| Main Authors: | S. Bracco, A. Mercato, M. Lacavalla, A. Cerro, S. Campanini, A. Genovesi, C. Farina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2024-12-01
|
| Series: | Microbiologia Medica |
| Online Access: | https://www.pagepressjournals.org/mm/article/view/13226 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria
by: Pablo Rubiñan, et al.
Published: (2024-11-01) -
Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. <i>Antibiotics</i> 2024, <i>13</i>, 874
by: Cristina Kirkegaard-Biosca, et al.
Published: (2024-12-01) -
Osteomyelitis Due to Multiple Carbapenemase-Producing Gram-Negative Bacteria: The First Case Report of a GES-13-Producing Pseudomonas aeruginosa Isolate in Canada
by: Shadi Sepehri, et al.
Published: (2014-01-01) -
Extended-spectrum beta-lactamase and carbapenemase-producing Gram-negative bacteria in urinary tract infections in Ethiopia: a systematic review and meta-analysis
by: Mitkie Tigabie, et al.
Published: (2025-01-01) -
Extended spectrum betalactamase and Carbapenemase producing gram negative bacteria from healthcare workers gowns at Debre Berhan Comprehensive Specialized Hospital, Ethiopia
by: Sisay Gebrish Sharew, et al.
Published: (2025-01-01)